← Companies|Palatin Technologies
PT

Palatin Technologies

PTN·NYSECranbury NJFounded 198615 employees
Micro CapbiotechPublicWomen's Health
Platform: MC4R Agonist
Market Cap
$0.02B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PTN)
Loading PTN stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
NidatinibPTN-7983Phase 22Small MoleculeWRNCl18.2Atopic DermRB
PolacagenePTN-5188Preclinical2mAbSMN2GLP-1agMS
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)
2026-07-26
Nidatinib Ph2 Data
Atopic Derm
Ph2 Data
2027-09-22
Nidatinib Ph2 Data
Atopic Derm
Ph2 Data
2030-05-14
Polacagene Interim
MS
Interim
2030-06-28
Polacagene Interim
MS
Interim